Skip to main content

Cellular Pharmacokinetics of Daunomycin in Human Leukemic Blasts In Vitro and In Vivo

  • Conference paper
Acute Leukemias II

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 33))

  • 152 Accesses

Abstract

The description of a decrease in the intracellular accumulation of a number of cytostatics, such as anthracyclines, vinca alkaloids, epipodophyllotoxins, and actinomycin D, in drug-resistant malignant cells — first demonstrated for colchicine in hamster ovary cells [4] caused by an energy-dependent outward pump in connection with the expression of the 170 000-dalton plasma membrane glycoprotein PI 70 [2] — has substantially contributed to the understanding of “multidrug resistance” [6]. Accordingly, the responsiveness of malignant cells to these cytotoxic drugs may more critically depend on their cellular tumor pharmacokinetics and metabolism than on their plasma pharmacokinetics, which in general only poorly correlates with their pharmacodynamics [7].

Supported by the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg:Sonderforschungsbereich 102

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G, Nowrousian MR, König HJ, Walter M, Wendt FC, Sodomann H, Hossfeld DK, von Paleske A, Löffler H, Gassmann W, Hellriegel K-P, Fülle HH, Lunscken C, Emmerich B, Pralle H, Pees HW, Pfreundschuh M, Bartels H, Koeppen K-M, Schwerdtfeger R, Donhuijsen-Ant R, Mainzer K, Bonfert B, Köppler H, Zurborn K-H, Ranft K, Thiel E, Heinecke A (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML):two multi-center studies of the German AML Cooperative Group. J Clin Oncol 3:1583–1589

    PubMed  Google Scholar 

  2. Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein associated with multi-drug resistance in mammalian cell lines. Science 221:1285–1288

    Article  PubMed  CAS  Google Scholar 

  3. Kokenberg E, van der Steuyt K, Löwenberg B, Sonneveld P (1987) Pharmacokinetics of daunorubicin as a determinant of response in acute myeloid leukemia. In:Büchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute leukemias. Prognostic factors and treatment strategies. Springer, Berlin Heidelberg New York, pp 283–287 (Hämatologie und Bluttransfusion, vol 30 )

    Google Scholar 

  4. Ling V, Thompson LH (1974) Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83:103–116

    Article  PubMed  CAS  Google Scholar 

  5. Ma DDF, Scurr RD, Davey RA, Mackertich SM, Harman DH, Dowden G, Isbister JP, Bell DR (1987) Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet i:135–137

    Article  Google Scholar 

  6. Pastan I, Gottesman M (1987) Multiple-drug resistance in human cancer. N Engl J Med 316:1388–1393

    Article  PubMed  CAS  Google Scholar 

  7. Powis G (1985) Anticancer drug pharmaco-dynamics. Cancer Chemother Pharmacol 14:177–183

    Article  PubMed  CAS  Google Scholar 

  8. Scheulen ME, Osieka R (1987) Increased activity of adriamycin against a human testicular cancer xenograft by cyclosporine A. Proc Amer Assoc Cancer Res 28:409

    Google Scholar 

  9. Scheulen ME, Hoensch H, Kappus H, Seeber S, Schmidt CG (1987) Positive correlation between decreased cellular uptake, NADPH-glutathione reductase activity and adriamycin resistance in Ehrlich ascites tumor. Arch Toxicol 60:154–157

    Article  PubMed  CAS  Google Scholar 

  10. Scheulen ME, Lennartz K, Heidrich T, Host G, Kramer B (1987) Determination of the cellular uptake of daunorubicin in human leukemia in vivo. Method of examination and first results. In:Buchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute leukemias. Prognostic factors and treatment strategies. Springer, Berlin Heidelberg New York, pp 298–301 (Hämatologie und Bluttransfusion, vol. 30 )

    Google Scholar 

  11. Speth PAJ, Linssen PCM, Boezeman JBM, Wessels HMC, Haanen C (1987) Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol 20:311–315

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Scheulen, M.E., Kramer, B., Skorzec, M., Reich, W.K. (1990). Cellular Pharmacokinetics of Daunomycin in Human Leukemic Blasts In Vitro and In Vivo. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74643-7_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50984-4

  • Online ISBN: 978-3-642-74643-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics